Work

Combination targeted treatment may enhance antitumor activity in ERBB3 amplified high-grade serous endometrial cancer cells resistant to single agent targeted therapy

Year: 2021

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(21)00860-x

Authors: Alyssa Larish, Wan Hsin Lin, James Smadbeck, Michael Barrett, Dorsay Sadeghian, Faye Harris, Jamie Lynch, Ryan Feathers, Angela Emanuel, Maureen Lemens, Leila Jones, Janet Schaefer Klein, Mitesh Borad, Aaron Mansfield, Stephen Murphy, George Vasmatzis, Panos Z Anastasiadis, Andrea Mariani, S. John Weroha

Institution: Mayo Clinic

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3194450713

FWCI:

Cites:

Cited by: 1

Related to: 10